Mirum Pharmaceuticals, Inc. , a leading rare disease company, today provided its preliminary and unaudited estimates for full-year 2025 net product sales, year-end cash balance, corporate updates and ...
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reports preliminary* fourth quarter and full-year 2025 net product revenues and cash, cash equivalents, ...
Morning Overview on MSN
Scientists spot the blood marker shared by people who hit 90+
Across large population studies, people who live into their nineties and beyond keep showing up with the same quiet signature ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...
Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer after CDK4/6 inhibitor treatment. The EPIK-B5 study reported a median ...
News-Medical.Net on MSN
Common blood signals explain why chronic diseases cluster as we age
This population-based study shows that shared and pattern-specific blood biomarkers reflect biological vulnerability ...
A small set of common blood biomarkers predicts which older adults will develop specific combinations of chronic diseases—and ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
We rounded up the best lab-grown diamonds from retailers with stellar reputations and a stunning array of jewelry to pick from. To make our selections, we tapped into our fashion team’s jewelry ...
A lab-on-a-chip is a class of device that integrates and automates multiple laboratory techniques into a system that fits on a chip up to a maximum of a few square centimetres in size. By manipulating ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback